Balyasny Asset Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-227,950	Closed	-$6.7M	–	2369
2024 Q3	$6.7M	Sell	227,950 -44,686	-16%	-$1.31M	0.01%	788
2024 Q2	$6.41M	Buy	272,636 +240,239	+742%	+$5.65M	0.01%	754
2024 Q1	$1.23M	Buy	+32,397	New	+$1.23M	﹤0.01%	1202